119 related articles for article (PubMed ID: 6535646)
21. Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts.
Hurme M; Chandler PR; Hetherington CM; Simpson E
J Exp Med; 1978 Mar; 147(3):768-75. PubMed ID: 416166
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of eight cell lines derived from human testicular teratocarcinoma.
Andrews PW; Bronson DL; Benham F; Strickland S; Knowles BB
Int J Cancer; 1980 Sep; 26(3):269-80. PubMed ID: 6169654
[TBL] [Abstract][Full Text] [Related]
23. Graft rejection in a congenic panel of rats with defined immune response genes for MHC class I antigens. I. Rejection of and priming to the RT1Aa antigen.
Stewart R; Butcher G; Herbert J; Roser B
Transplantation; 1985 Oct; 40(4):427-32. PubMed ID: 3931316
[TBL] [Abstract][Full Text] [Related]
24. Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.
Ostrand-Rosenberg S; Clements V
Immunogenetics; 1987; 26(1-2):1-5. PubMed ID: 3301646
[TBL] [Abstract][Full Text] [Related]
25. Somatic cell origin of teratocarcinomas.
Mintz B; Cronmiller C; Custer RP
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2834-8. PubMed ID: 275854
[TBL] [Abstract][Full Text] [Related]
26. Identification of a mouse male-specific transplantation antigen, H-Y.
Scott DM; Ehrmann IE; Ellis PS; Bishop CE; Agulnik AI; Simpson E; Mitchell MJ
Nature; 1995 Aug; 376(6542):695-8. PubMed ID: 7544442
[TBL] [Abstract][Full Text] [Related]
27. Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.
Maher LJ; Dove WF
Immunogenetics; 1984; 19(4):343-7. PubMed ID: 6715024
[No Abstract] [Full Text] [Related]
28. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection.
Ostrand-Rosenberg S; Clements VK; Thakur A; Cole GA
J Immunogenet; 1989; 16(4-5):343-9. PubMed ID: 2639907
[TBL] [Abstract][Full Text] [Related]
29. Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.
Shedlovsky A; Clipson LJ; VandeBerg JL; Dove WF
Immunogenetics; 1981; 13(5):413-9. PubMed ID: 7298086
[TBL] [Abstract][Full Text] [Related]
30. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
Lehtonen E; Laasonen A; Tienari J
Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
[TBL] [Abstract][Full Text] [Related]
31. Teratocarcinoma transplantation antigens are encoded in the H-2 region.
Johnson LL; Clipson LJ; Dove WF; Feilbach J; Maher LJ; Shedlovsky A
Immunogenetics; 1983; 18(2):137-45. PubMed ID: 6350173
[TBL] [Abstract][Full Text] [Related]
32. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous histocompatibility mutations detected by dermal grafts: significant changes in rate over a 10-year period in the mouse H-system.
Kohn HI; Melvold RW
Mutat Res; 1974 Aug; 24(2):163-9. PubMed ID: 4605140
[No Abstract] [Full Text] [Related]
34. Regulation of major histocompatibility gene expression in teratocarcinoma 402AX cells.
Ostrand-Rosenberg S; Clements V; Cole G; DeCloux A; Marr L; Schwartzman M
Cell Differ; 1984 Dec; 15(2-4):221-7. PubMed ID: 6336034
[TBL] [Abstract][Full Text] [Related]
35. Genetic control of the immune response. Mapping of the Ir-1 locus.
McDevitt HO; Deak BD; Shreffler DC; Klein J; Stimpfling JH; Snell GD
J Exp Med; 1972 Jun; 135(6):1259-78. PubMed ID: 4554451
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of the growth and differentiation of teratocarcinoma OC15S1 in syngeneic and allogeneic mice].
Dyban PA
Biull Eksp Biol Med; 1984 Jan; 97(1):71-2. PubMed ID: 6692027
[TBL] [Abstract][Full Text] [Related]
37. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor.
Andrews PW; Damjanov I; Simon D; Dignazio M
Differentiation; 1985; 29(2):127-35. PubMed ID: 2412924
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a histocompatibility locus probably linked to but distinct from Mls and H-25.
Berumen L; Halle-Pannenko O
J Immunogenet; 1988; 15(1-3):49-58. PubMed ID: 3148665
[TBL] [Abstract][Full Text] [Related]
39. Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains.
Cudkowicz G
J Exp Med; 1971 Jul; 134(1):281-93. PubMed ID: 4934149
[TBL] [Abstract][Full Text] [Related]
40. Male-specific transplantation antigen expression by XY teratocarcinomas PCC7 and 7'.
Johnson LL; Dove WF
Immunogenetics; 1984; 19(3):233-41. PubMed ID: 6368378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
